ITC Issues Ban on Infringing Photodynamic Therapy Imports
Published Date: 5/11/2026
Notice
Summary
The U.S. International Trade Commission found that some photodynamic therapy devices and related products imported by certain companies broke patent rules. To fix this, they’re blocking these products from entering the U.S. without permission and ordering the companies to stop selling them. This means affected businesses must act fast or face legal and financial consequences.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Limited Exclusion Order blocking imports
The Commission issued a Limited Exclusion Order (LEO) prohibiting the unlicensed entry into the United States of infringing photodynamic therapy systems, components, and pharmaceutical products that are manufactured by or on behalf of the named respondents or their affiliates. The determination was made by Commission vote on May 6, 2026 and applies to products found to infringe the asserted patents.
Cease-and-desist orders for named respondents
The Commission issued cease-and-desist orders (CDOs) against each named respondent — Biofrontera Inc.; Biofrontera Pharma GmbH; Biofrontera Bioscience GmbH; and Biofrontera AG — requiring them to stop selling the infringing photodynamic therapy systems, components, and related pharmaceutical products. The Commission terminated the investigation after issuing these orders following its May 6, 2026 vote.
Zero percent bond during Presidential review
The Commission set a bond of zero percent (0%) for any importations of the infringing products during the period of Presidential review, under 19 U.S.C. 1337(j). This means importers would not have to post a monetary bond for the covered products during that review period.
Orders suspended for '028 patent pending appeals
The Commission suspended the remedial orders as to U.S. Patent No. 11,697,028 (the '028 patent) in light of a Final Written Decision (FWD) from the Patent Trial and Appeal Board and pending any further action before the Board or potential appeals. The suspension applies while the Board and any appeals remain active.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22911, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Honeywell Aerospace about some electronic control units that might be breaking import rules. Companies like Lucid and Rivian are involved, and the Commission wants your thoughts on how this affects the public. This could lead to import bans or sales stops soon, so keep an eye out if you’re connected to these products or companies.
2026-22904, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Netlist, Inc. about certain memory devices like DRAM and NAND flash being imported and sold in the U.S. The complaint targets big tech companies like Kingston and Lenovo, and the Commission wants your thoughts on how this might affect the public. This could lead to changes in what memory products are allowed, so keep an eye out for updates!
2026-22923, Prestressed Concrete Steel Wire Strand From China; Determinations
The U.S. International Trade Commission decided to keep special taxes on prestressed concrete steel wire strand imported from China. This means U.S. companies making this steel are protected from unfairly cheap imports that could hurt their business. The decision was made in November 2026 and signals ongoing support for American steel makers.
2026-22768, Certain Glow Fish Tape Systems, Safety Helmet Systems, and Components Thereof; Notice of a Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Order; Termination of Investigation
The U.S. International Trade Commission found Milwaukee Electric Tool guilty of selling glow fish tape systems that break a patent owned by Klein Tools. Milwaukee must stop selling these products in the U.S. and face a limited ban on imports, with a 100% bond on any shipments during review. This means Milwaukee’s glow fish tape systems are officially off-limits, protecting Klein’s invention and shaking up the market.
2026-22730, Certain Foundry Coke; Notice of a Commission Determination Not To Review an Initial Determination Granting Complainants' Motion To Amend the Complaint and Notice of Investigation and To Terminate the Investigation as to Certain Claims
The U.S. International Trade Commission has agreed to let SunCoke add more patent claims against MTX Group in their foundry coke case and dropped all claims related to another patent against all parties. This means the investigation will focus on specific patent issues with MTX Group, speeding things up and sharpening the fight over imported foundry coke. If you’re involved, keep an eye on this as it could affect sales and imports soon.
2026-22595, Seamless Refined Copper Pipe and Tube From Vietnam; Scheduling of an Expedited Five-Year Review
The U.S. International Trade Commission is speeding up a review to decide if special taxes on seamless refined copper pipe and tube from Vietnam should stay or go. This affects U.S. businesses that make or sell these pipes and tubes, as well as importers from Vietnam. The decision, starting October 5, 2026, could impact prices and trade rules soon.
Previous / Next Documents
Previous: 2026-09242, Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm)
The FDA just gave Denali Therapeutics a special priority review voucher for their rare pediatric disease drug AVLAYAH, approved in March 2026. This voucher speeds up the review of future medicines, helping kids with rare diseases get treatments faster. It’s a big win for patients, the company, and anyone watching rare disease drug development!
Next: 2026-09244, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products
The FDA is asking for public comments on their plan to keep testing how they communicate about medical devices and radiation products. This helps them make sure their messages reach patients, caregivers, and healthcare pros clearly and effectively. Comments are due by June 10, 2026, and this review won’t cost anyone extra but will improve important health info.